The Medical Letter on Drugs and Therapeutics
ONLINE
ONLY
ARTICLE
ONLY
ARTICLE
July 26, 2021
Yutiq - Another Fluocinolone Intravitreal Implant for Uveitis (online only)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Yutiq - Another Fluocinolone Intravitreal Implant for Uveitis (online only)
July 26, 2021 (Issue: 1629)
Yutiq (Eyepoint), an intravitreal implant containing
the corticosteroid fluocinolone acetonide, has been
approved by the FDA for treatment of chronic noninfectious
uveitis affecting the posterior segment of the
eye. It is the third fluocinolone...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.